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IntroductIon
Hemodialysis is the diffusion of molecules in solution across a se-
mipermeable membrane through an electrochemical concentration 
gradient. The main objective of hemodialysis is to repair the intra-
cellular and extracellular fluid environment. This is accomplished by 
the transport of solutes such as urea from the blood into the dialysate 
and by the transport of solutes such as bicarbonate from the dialysate 
into the blood(1,2). Hemodialysis is required for the survival of patients 
with renal failure and end-stage renal disease (ESRD) by filtering the 
blood, it corrects the excessive accumulation and abnormal distribu-
tion of solutes in body fluids(3). Thus, changes in the systemic hemo-
dynamic and metabolic parameters associated with hemodialysis 
may affect ocular fluid dynamics and composition, blood vessels, 
tissues of the retina, the choroid, and the optic nerve(4-6).
The choroid provides oxygen and nutrients to the outer layers 
of the retina as well as the visible pigmentation of the fundus. The 
choroidal vessels can expand and contract easily, so that changes in 
intraocular or extraocular vascular pressure can affect the choroidal 
thickness(7). Because the choroid plays an important role in the pa-
thophysiology of many retinal diseases, it is important to understand 
the anatomic structure and functional status of the choroid(8). Optical 
coherence tomography (OCT) is a noninvasive, interferometric opti-
cal imaging technique that provides high-resolution cross-sectional 
images of the retina using the reflectivity of light waves(9,10).
Evaluation of the choroid using spectral-domain optical coherence 
tomography (SD-OCT) was recently reported to be valuable because 
choroidal change has been associated with the pathogenesis of 
ocular diseases, such as central serous chorioretinopathy, age-related 
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ABStrAct
Purpose: To assess the effect of hemodialysis on retinal and choroidal thicknesses 
using spectral-domain optical coherence tomography (SD-OCT). 
Methods: In this prospective interventional study, 25 hemodialysis patients 
(17 male, 8 female) were enrolled. All participants underwent high-speed, 
high-resolution SD-OCT (λ=840 mm; 26.000 A-scans/s; 5 µm resolution) before and 
after hemodialysis. Choroidal thickness was measured perpendicularly from the 
outer edge of the retinal pigment epithelium to the choroid-sclera boundary at 
the fovea and at five additional points: 500 μm and 1000 μm nasal to the fovea 
and 500 μm, 1000 μm, and 1500 μm temporal to the fovea. Two masked physicians 
performed the measurements. Choroidal and retinal thicknesses before and after 
hemodialysis were compared.
results: The median choroidal thicknesses before and after hemodialysis were 
182 µm (range, 103-374 µm) and 161 µm (range, 90-353 µm), respectively (P<0.001). 
The median retinal thicknesses were 246 µm (range, 179-296 µm) before and 248 µm 
(range, 141-299 µm) after hemodialysis (P>0.05). Systolic arterial pressure, diastolic 
arterial pressure, mean arterial pressure, heart rate, and ocular perfusion pressure 
significantly decreased after hemodialysis (P<0.001). Intraocular pressure did not 
vary significantly (P=0.540). 
conclusion: Hemodialysis seems to cause a significant decrease in choroidal 
thickness, whereas it has no effect on retinal thickness. This significant decrease in 
choroidal thickness might be due to the extensive fluid absorption in hemodialysis, 
which could result in decreased ocular blood flow.
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RESUMO
Objetivo: Avaliar o efeito da hemodiálise (HD) na espessura da retina (RT ) e na 
es pessura da coroide (CT ) usando tomografia de coerência óptica de domínio es­
pectral (SD­OCT ). 
Método: Neste estudo prospectivo intervencionista foram incluídos 25 pacientes em 
HD (17 homens e 8 mulheres). Todos os participantes foram submetidos a SD­OCT 
com dispositivo de alta resolução (λ=840 mm; 26.000 A­scans/seg e resolução de 
5 µm), antes e após HD. A CT foi medida perpendicularmente a partir da borda externa 
do epitélio pigmentar da retina até o limite coroide­esclera na fóvea e em mais de 5 
pontos localizados 500 µm nasal à fóvea, 1.000 µm nasal à fóvea; 500 µm temporal 
à fóvea, 1.000 µm temporal à fóvea, e 1.500 µm temporal à fóvea. Dois médicos rea­
lizaram as medidas sem o conhecimento do diagnóstico. Os dados da CT e RT, antes 
e após a HD foram comparados. 
Resultados: As CTs medianas antes e após a HD foram 182 µm (variação de 103­
374 µm) e 161 µm (variação de 90­353 µm), respectivamente (p<0,001). A RT foi 
246 µm (variação de 179­296 µm) antes e 248 µm (variação de 141­299 µm) após 
a HD (p>0,05). A pressão arterial sistólica, pressão arterial diastólica, as médias 
de pressão arterial média, frequência cardíaca e pressão de perfusão ocular dimi­
nuí ram significativamente após HD (p<0,001). A pressão intraocular não alterou 
sig ni ficativamente (p=0,540). 
Conclusão: A HD parece causar uma redução significativa da CT, e não ter efeito 
sobre a RT. Esta redução significativa da CT pode ser devida à grande absorção de 
fluido durante a HD, o que pode resultar numa diminuição do fluxo sanguíneo ocular.
Descritores: Espessura da coroide; Hemodiálise; Tomografia de coerência óptica
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macular degeneration, diabetic retinopathy, as well as in eyes with 
tilted optic discs, the healthy pediatric population, and pregnant 
women(11-16).
A recent study showed a significant increase in choroidal thickness 
after hemodialysis, whereas several other studies have shown a signi-
ficant decrease in choroidal thickness after hemodialysis(17-20).
In this study, we investigated the changes in retinal and choroidal 
thicknesses before and after high-ultrafiltration-volume hemodialysis 
in patients with ESRD.
MethodS
Study deSign
Twenty-five non-diabetic ESRD patients (17 male, 8 female) 
undergoing hemodialysis in the Hemodialysis Unit of the Baskent 
University Faculty of Medicine were enrolled in this prospective study. 
The study was approved by the ethics committee of the Baskent 
University Faculty of Medicine. The research adhered to the tenets 
of the Declaration of Helsinki, and a detailed written informed con-
sent form was obtained prior to each individual’s participation in 
the study. The inclusion criteria were a best corrected visual acuity 
exceeding 20/200; no history of chronic ocular diseases, such as glau-
coma, uveitis, age-related macular degeneration, retinal artery/vein 
occlusion, or diabetic retinopathy; no family history of glaucoma; and 
the presence of non-diabetic ESRD treated by hemodialysis with an 
ultrafiltration volume >2000 mL because of high interdialytic weight 
gain. The exclusion criteria were the presence of an ocular disease 
that prevented the examination of the cornea, lens, and retina; an 
ocular surgery and/or laser treatments and/or intravitreal injection of 
the eye; spherical equivalent refractive errors more than ± 3.0 diopters; 
and axial length between 22 mm and 24 mm. The subjects underwent 
a 3- to 4-h hemodialysis session three times weekly using a high-per-
formance dialyzer at a blood flow rate of 250-300 mL/min and a stan-
dardized dialysate flow rate of 500 mL/min. A bicarbonate-containing 
dialysis solution was used during the hemodialysis. The causes of 
ESRD in the twenty-five patients included polycystic kidney disease 
(n=3), chronic glomerulonephritis (n=3), hypertensive nephropathy 
(n=13), renal amyloidosis due to familial Mediterranean fever (n=2), 
renal excision due to renal cancer (n=2), and chronic renal failure of 
unknown etiology (n=2). 
All patients underwent a detailed ophthalmic examination that 
in cluded visual acuity testing; refraction assessments using an auto 
refractometer; biomicroscopy; intraocular pressure measurement 
with Goldman applanation tonometry; fundus examination; and cho-
roidal and retinal thickness measurements using OCT just before and 
after their hemodialysis sessions. One eye per patient was randomly 
selected for OCT measurement. Randomization was done using a 
random number generator. To obtain clear images and minimize the 
effect of axial length on choroidal thickness, measurements with a 
refractive error higher than 1 diopter were excluded from the study(21).
MeaSureMent of retinal/choroidal thickneSS
Choroidal thickness measurements were performed by the same 
experienced technician just before and immediately after hemo-
dialysis using a high-speed, high-resolution SD-OCT device (λ=840 nm; 
26,000 A-scans/s; 5 μm axial resolution). The results were analyzed 
using Optovue RTVue software version 3.5 (Optovue Inc., Fremont, 
CA). The retinal image was obtained after the patient was correctly 
positioned; the OCT device was pushed toward the eye while the pa-
tient maintained fixation. The scan pattern followed the retinal cross 
line, which consisted of two orthogonally oriented 6 mm lines that 
contained 1024 A-scans. By automatically inverting the image, the 
chorioretinal interface became adjacent to the zero delay. The retinal 
cross-line scan had an average of 32 frames, 16 per direction, without 
tracking(22). All basal OCT scans were performed at the same time of 
the day to minimize diurnal fluctuations(23). Choroidal thickness was 
measured perpendicularly from the outer edge of the retinal pigment 
epithelium to the choroid-sclera boundary at the fovea and at five 
more points located at the fovea; 500 μm and 1000 μm nasal to the fovea 
and 500 μm, 1000 μm, and 1500 μm temporal to the fovea (Figure 1). 
Choroidal thickness measurements were performed by two masked 
physicians (AK and CK). The average of the three measurements was 
taken; the differences between readings of the masked physicians 
were found to be within 10 μm of the mean. The interexaminer re-
producibility of the choroidal thickness measurements was assessed 
by measuring the intraclass correlation coefficient (ICC).
StatiStical analySiS
Statistical analyses were performed using the Statistical Package 
for the Social Sciences (SPSS) version 11.0 (SPSS Inc, Chicago, IL, USA). 
The Wilcoxon test was used to compare the systemic hemodyna-
mic and ocular variables before and after hemodialysis in each group. 
Differences between the groups were analyzed using the Mann-Whitney 
U test. The intraclass correlation coefficient (ICC) was calculated to 
quantify the reproducibility of manual re-measurements of the cho-
roidal and retinal thicknesses in cases of alignment errors. The ocular 
perfusion pressure (OPP) was calculated using the following formula: 
OPP=2/3 × (mean arterial pressure - intraocular pressure). The mean 
arterial pressure (MAP) was calculated using the following formula: 
MAP=diastolic arterial pressure - 1/3 × (systolic arterial pressure - dias-
tolic arterial pressure). Differences resulting in P values of <0.05 were 
considered statistically significant.
reSuLtS
General patient information is presented in table 1. The median 
choroidal thickness at the fovea decreased significantly during he-
modialysis; changing from 182 µm (range, 103-374 µm) to 161 µm 
(range, 90-353 µm) (P<0.001). Moreover, significant differences in me-
dian choroidal thicknesses were found before and after hemodialysis 
at all points where measurements were taken (P<0.001 for all) (Figure 2). 
table 1. General patient information
Age Mean ± Sd range
Sex 44.6 ± 12.7 20-60
Male 17.0 (68%)
Female 08.0 (32%)
HD duration (months) 42.8 8.0-76.0
Ultrafiltration volume (mL) 3136.0 ± 578.0 2000-4500
HD= hemodialysis; SD= standard deviation. 
Figure 1. T-1500, choroidal thickness at 1500 μm temporal to the fovea; T-1000, choroi-
dal thickness at 1000 μm temporal to the fovea; T-500, choroidal thickness at 500 μm 
tem poral to the fovea; F, choroidal thickness at the fovea; N-500, choroidal thickness at 
500 μm nasal to the fovea; N-1000, choroidal thickness at 1000 μm nasal to the fovea; 
N-1500, choroidal thickness at 1500 μm nasal to the fovea.
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However, hemodialysis did not cause a significant decrease in median 
retinal thickness (246 µm [range, 179-296 µm] before versus 248 µm 
[range, 141-299 µm] after hemodialysis; [P=0.12]). The interexaminer 
ICCs for the choroidal and retinal thicknesses were 0.918 (95% con-
fidence interval [CI], 0.908-0.982) and 0.922 (95% CI, 0.906-0.979), 
respectively. The ICC was greater than 0.90 for measurements taken 
at all points. Figure 3 shows a comparison of the median choroidal 
and retinal thicknesses measured by two different observers before 
and after hemodialysis. Systolic arterial pressures (SAPs), diastolic 
arterial pressures (DAPs), MAPs, ıntraocular pressures (IOPs), heart 
rates, and OPPs before and after hemodialysis are presented table 2. 
Decreases in heart rate, SAP, DAP, MAP, and OPP were statistically 
significantly (P<0.001), but the change in IOP was not statistically 
significant (P=0.540). 
dIScuSSIon
In this current study, choroidal thickness measurements taken at 
six different points decreased significantly during hemodialysis, but 
foveal retinal thickness did not change. These findings could be the 
result of choroidal changes associated with hypertension and fluid 
retention in renal failure patients. Decreased plasma colloidal osmotic 
pressure due to decreased serum protein levels and increased 
hydrostatic pressure associated with hypertension may also alter the 
hemodynamics in the retinal capillaries. Prior to hemodialysis, fluid 
retention causes a decrease in plasma colloidal osmotic pressure due 
to the increased plasma volume. Because this decrease produces a 
colloidal osmotic gradient between the plasma and interstitial volume, 
water passes from the interstitial fluid into the plasma(24). Changes in 
MAP affect the blood velocity and retinal blood flow positively, and 
hemodialysis leads to changes in systemic circulatory parameters 
such as hematocrit, systemic blood pressure (SBP), and the amount of 
fluid circulation in ESRD patients. The main mechanism driving dimi-
nished retinal blood flow during hemodialysis is hypothesized to be 
related to the amount of fluid removed during hemodialysis. Retinal 
blood flow and the amount of fluid removed by hemodialysis were 
found to be negatively correlated(6). Because the aim of hemodialysis 
is to correct the abnormal distribution of bodily fluids, ocular hemo-
dynamics are expected to be affected by this rearrangement. In one 
study, researchers reported several hemodialysis-related changes, 
including decreased visual acuity, IOP, corneal thickness, and basal 
tear secretion; however, the authors found no significant change in 
retinal thickness using SD-OCT(4). The authors concluded that the 
shifting of water from the interstitial fluid into the plasma results in 
a drop in tear secretion, aqueous production, and corneal hydration. 
In another study, researchers reported that the IOP, OPP, and SAP did 
not vary significantly in ESRD patients during hemodialysis(25). We also 
did not observe a significant change in IOP; however, OPP, SAP, DAP, 
and MAP decreased significantly. In another study, researchers found 
decreases in both the systolic and diastolic blood flow velocities of 
the ophthalmic artery, central retinal artery, central retinal vein, and 
nasal and temporal posterior ciliary arteries of both eyes after hemo-
dialysis(26). Their study was conducted using color Doppler imaging. 
We consider that a loss of interstitial fluid and a decrease in ocular 
blood flow were the two underlying causes of the significant decrea se 
in choroidal thickness detected in this current study. 
In a recent study, researchers reported that choroidal thickness 
increased and SBP decreased after a hemodialysis session(17). They 
proposed that the increase in choroidal thickness may be associated 
with choroidal autoregulatory control of ocular hemodynamics; a 
shifting of fluid and molecules between the plasma and choroidal 
in terstitium. On the other hand, other researchers have reported a 
significant decrease in choroidal thickness after hemodialysis(18-20). 
They assert that ultrafiltration-dependent hypovolemia, the removal 
of intravascular and interstitial fluid due to raised plasma colloid 
osmotic pressure(18,19), and a reduction in the area of the choroidal 
vasculature(20) may cause the decrease in choroidal thickness. Our re-
sults are similar to the results of these studies. In one of these studies, 
it was reported that the decrease in choroidal thickness following 
hemodialysis was higher in patients with diabetes than in patients 
without diabetes. The authors stated that this decrease was due to a 
damage to the choroidal vessels in patients with diabetes(19).
With the availability of SD-OCT devices, high-resolution images 
are now available. This gives the clinician enough information to eva-
luate the choroid more accurately(8,27). As a highly vascular ocular 
structure, the choroid is directly influenced by the IOP and OPP(27); 
therefore, real-time, high-definition images of the choroid could help us 
Figure 2. Median choroidal thickness measurements before and after hemodialysis.
Figure 3. Comparison of choroidal measurements taken before and after hemodialysis 
by two different observers. 
table 2. effect of hemodialysis on systemic and ocular parameters
Before hd After hd
P value  mean ± Sd mean ± Sd
IOP (mmHg) 016.8 ± 03.0 016.7 ± 03.6 <0.540
Heart rate (beats/min) 077.2 ± 05.4 074.2 ± 05.1 <0.001
Blood pressure (mmHg)
Systolic 131.6 ± 13.1 119.0 ± 10.7 <0.001
Diastolic 082.6 ± 11.1 070.8 ± 09.3 <0.001
Mean 098.6 ± 10.6 087.2 ± 09.1 <0.001
Ocular perfusion pressure 048.9 ± 08.5 041.4 ± 07.3 <0.001
HD= hemodialysis; mmHg= millimeters of mercury; SD= standard deviation.
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demonstrate the real-time vascular status of this tissue in vivo. A 
group of researchers found an age-correlated decrease in retinal 
thickness in all quadrants in hemodialysis patients compared with 
healthy controls(28).
There were some limitations to our study. Serum osmolarity, plasma 
colloid serum osmotic pressure, and anterior segment parameters 
were not measured. These parameters could also be correlated with 
choroidal thickness changes. 
In conclusion, we found no retinal thickness changes and signifi-
cant choroidal thickness changes following hemodialysis in patients 
with ESRD. Because the choroid has little autoregulation, blood flow 
can be affected by changes in the perfusion pressure and choroidal 
thickness can be changed as a result of these effects. Further rando-
mized trials with larger patient groups and additional systemic para-
meters could shed more light on this issue.
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